Resident physician extended work hours and burnout

Andrew W. McHill; Charles A. Czeisler; Steven A. Shea

doi:10.1093/sleep/zsy112

Resident physician extended work hours and burnout

Andrew W. McHill, Charles A. Czeisler, Steven A. Shea

Oregon Institute of Occupational Health Sciences

Research output: Contribution to journal › Editorial › peer-review

3 Scopus citations

Original language	English (US)
Journal	Sleep
Volume	41
Issue number	8
DOIs	https://doi.org/10.1093/sleep/zsy112
State	Published - Aug 1 2018

ASJC Scopus subject areas

Clinical Neurology
Physiology (medical)

Access to Document

10.1093/sleep/zsy112

Cite this

@article{6afd2206171c48f282d4ec19b22031c1,

title = "Resident physician extended work hours and burnout",

author = "McHill, {Andrew W.} and Czeisler, {Charles A.} and Shea, {Steven A.}",

note = "Funding Information: Dr. McHill is supported by NIH KL2TR002370. Dr. Shea is supported by the Oregon Institute of Occupational Health Sciences at Oregon Health & Science University via funds from the Division of Consumer and Business Services of the State of Oregon. Outside of the current work, Dr. Shea also receives support from National Institutes of Health (NIH) grants R01 HL142064, R01 HL125893, HL125893-03S1, and R01 HL140577 (to S.A. Shea), DoD grant PT150133 (to L. Hammer), and CDC grant U19 OH010154 (to W.K. Anger). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding Information: Conflict of interest statement. A.W.M. and S.A.S have nothing to disclose; C.A.C. has received consulting fees from or served as a paid member of scientific advisory boards for the following: Columbia River Bar Pilots; Gan{\'e}sco Inc.; Institute of Digital Media and Child Development; Klarman Family Foundation; Samsung Electronics; Vanda Pharmaceuticals; Washington State Board of Pilotage Commissioners; and Zurich Insurance Company, Ltd. C.A.C. has also received education/research support from Optum, Philips Respironics, Inc., San Francisco Bar Pilots, Schneider Inc., Sysco, and Vanda Pharmaceuticals. The Sleep and Health Education Program of the Harvard Medical School Division of Sleep Medicine, and the Sleep Matters Initiative (which C.A.C. directs) have received funding for educational activities from Cephalon, Inc., Jazz Pharmaceuticals, ResMed, Takeda Pharmaceuticals, Teva Pharmaceuticals Industries Ltd., Sanofi-Aventis, Inc., Sepracor, Inc., Wake Up Narcolepsy, and Mary Ann & Stanley Snider via Combined Jewish Philanthropies. C.A.C. is the incumbent of an endowed professorship provided to Harvard University by Cephalon, Inc. and holds a number of process patents in the field of sleep/circadian rhythms (e.g. photic resetting of the human circadian pacemaker). Since 1985, C.A.C. has also served as an expert on various legal and technical cases related to sleep and/or circadian rhythms including those involving the following commercial entities: Complete General Construction Company, FedEx, Greyhound, HG Energy LLC, South Carolina Central Railroad Co., Stric-Lan Companies LLC, and United Parcel Service (UPS). C.A.C. owns or owned an equity interest in Vanda Pharmaceuticals. He received royalties from Houghton Mifflin Harcourt/Penguin, McGraw Hill, and Koninklijke Philips Electronics, N.V. for the Actiwatch-2 and Actiwatch-Spectrum devices. Dr. Czeisler{\textquoteright}s interests were reviewed and managed by Brigham and Women{\textquoteright}s Hospital and Partners HealthCare in accordance with their conflict of interest policies.",

year = "2018",

month = aug,

day = "1",

doi = "10.1093/sleep/zsy112",

language = "English (US)",

volume = "41",

journal = "Sleep",

issn = "0161-8105",

publisher = "American Academy of Sleep Medicine",

number = "8",

}

TY - JOUR

T1 - Resident physician extended work hours and burnout

AU - McHill, Andrew W.

AU - Czeisler, Charles A.

AU - Shea, Steven A.

N1 - Funding Information: Dr. McHill is supported by NIH KL2TR002370. Dr. Shea is supported by the Oregon Institute of Occupational Health Sciences at Oregon Health & Science University via funds from the Division of Consumer and Business Services of the State of Oregon. Outside of the current work, Dr. Shea also receives support from National Institutes of Health (NIH) grants R01 HL142064, R01 HL125893, HL125893-03S1, and R01 HL140577 (to S.A. Shea), DoD grant PT150133 (to L. Hammer), and CDC grant U19 OH010154 (to W.K. Anger). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding Information: Conflict of interest statement. A.W.M. and S.A.S have nothing to disclose; C.A.C. has received consulting fees from or served as a paid member of scientific advisory boards for the following: Columbia River Bar Pilots; Ganésco Inc.; Institute of Digital Media and Child Development; Klarman Family Foundation; Samsung Electronics; Vanda Pharmaceuticals; Washington State Board of Pilotage Commissioners; and Zurich Insurance Company, Ltd. C.A.C. has also received education/research support from Optum, Philips Respironics, Inc., San Francisco Bar Pilots, Schneider Inc., Sysco, and Vanda Pharmaceuticals. The Sleep and Health Education Program of the Harvard Medical School Division of Sleep Medicine, and the Sleep Matters Initiative (which C.A.C. directs) have received funding for educational activities from Cephalon, Inc., Jazz Pharmaceuticals, ResMed, Takeda Pharmaceuticals, Teva Pharmaceuticals Industries Ltd., Sanofi-Aventis, Inc., Sepracor, Inc., Wake Up Narcolepsy, and Mary Ann & Stanley Snider via Combined Jewish Philanthropies. C.A.C. is the incumbent of an endowed professorship provided to Harvard University by Cephalon, Inc. and holds a number of process patents in the field of sleep/circadian rhythms (e.g. photic resetting of the human circadian pacemaker). Since 1985, C.A.C. has also served as an expert on various legal and technical cases related to sleep and/or circadian rhythms including those involving the following commercial entities: Complete General Construction Company, FedEx, Greyhound, HG Energy LLC, South Carolina Central Railroad Co., Stric-Lan Companies LLC, and United Parcel Service (UPS). C.A.C. owns or owned an equity interest in Vanda Pharmaceuticals. He received royalties from Houghton Mifflin Harcourt/Penguin, McGraw Hill, and Koninklijke Philips Electronics, N.V. for the Actiwatch-2 and Actiwatch-Spectrum devices. Dr. Czeisler’s interests were reviewed and managed by Brigham and Women’s Hospital and Partners HealthCare in accordance with their conflict of interest policies.

PY - 2018/8/1

Y1 - 2018/8/1

UR - http://www.scopus.com/inward/record.url?scp=85055651238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055651238&partnerID=8YFLogxK

U2 - 10.1093/sleep/zsy112

DO - 10.1093/sleep/zsy112

M3 - Editorial

C2 - 29901751

AN - SCOPUS:85055651238

VL - 41

JO - Sleep

JF - Sleep

SN - 0161-8105

IS - 8

ER -